Literature DB >> 10781908

The alpha(2A) adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice.

Wade S Kingery1, Tian Z Guo, Frances M Davies, Lee Limbird, Mervyn Maze.   

Abstract

We have addressed the role of the sympathetic nervous system in the development and maintenance of neuropathic pain. Using a new neuropathic mouse model, we examined the development of hyperalgesia in transgenic mice lacking functional alpha(2A) adrenoceptors and in sympathectomized wild-type mice, to determine if sympathetic-sensory coupling generates hyperalgesia. The development of neuropathic heat hyperalgesia required the presence of both the alpha(2A) adrenoceptor and the sympathetic postganglionic neuron (SPGN), but the development of mechanical hyperalgesia did not require either the alpha(2A) adrenoceptor or the SPGN, indicating different mechanisms of sensitization. These results suggest that the development of neuropathic heat hyperalgesia, but not mechanical hyperalgesia, requires sympathetic-sensory coupling in the peripheral nervous system. Nerve injury enhanced the analgesic efficacy of the alpha(2) adrenoceptor agonist dexmedetomidine, and paradoxically also induced an analgesic response to alpha(2) adrenoceptor antagonists. The alpha(2) agonist-evoked analgesia to mechanical stimuli was mediated by activating central alpha(2A) adrenoceptors, possibly at the spinal level. The peripherally restricted alpha(2) antagonist L659,066 evoked analgesia for heat, but not for mechanical stimuli, findings which support the hypothesis that the peripheral alpha(2) adrenoceptor plays a role in both the development and the maintenance of neuropathic heat hyperalgesia. The alpha(2) antagonist-evoked analgesia for heat stimuli was mediated by blocking peripheral and probably central alpha(2) adrenoceptors, while the analgesia for mechanical stimuli was mediated by blocking central alpha(2A) adrenoceptors. Intradermal injections with an alpha(2) agonist or antagonist had no effect on nociceptive thresholds, indicating that sympathetic-sensory coupling at the level of the cutaneous nociceptor did not contribute to the maintenance of neuropathic hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781908     DOI: 10.1016/S0304-3959(99)00286-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

1.  Noradrenaline regulates substance P release from rat dorsal root ganglion neurons in vitro.

Authors:  Yan-Jie Wang; Xing-Fu Li; Feng Ding; Qiang Shu; Li-Jun Song; Xiao Yu; Hua-Xiang Liu
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

Review 2.  Analgesic synergy between opioid and α2 -adrenoceptors.

Authors:  A-J Chabot-Doré; D J Schuster; L S Stone; G L Wilcox
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Involvement of selective alpha-2 adrenoreceptor in sympathetically maintained pain.

Authors:  Chan Hong Park; An Yong; Sang Ho Lee
Journal:  J Korean Neurosurg Soc       Date:  2010-06-30

4.  A peripheral adrenoceptor-mediated sympathetic mechanism can transform stress-induced analgesia into hyperalgesia.

Authors:  John E Donello; Yun Guan; Mingting Tian; Cynthia V Cheevers; Miguel Alcantara; Sara Cabrera; Srinivasa N Raja; Daniel W Gil
Journal:  Anesthesiology       Date:  2011-06       Impact factor: 7.892

Review 5.  The potential contribution of stress systems to the transition to chronic whiplash-associated disorders.

Authors:  Samuel A McLean
Journal:  Spine (Phila Pa 1976)       Date:  2011-12-01       Impact factor: 3.468

6.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

7.  Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.

Authors:  Wenwu Li; Xiaoyou Shi; Liping Wang; Tianzhi Guo; Tzuping Wei; Kejun Cheng; Kenner C Rice; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2013-04-12       Impact factor: 6.961

Review 8.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

9.  Epinephrine, phenylephrine, and methoxamine induce infiltrative anesthesia via alpha1-adrenoceptors in rats.

Authors:  Ja-ping Shieh; Chin-chen Chu; Jhi-joung Wang; Mao-tsun Lin
Journal:  Acta Pharmacol Sin       Date:  2009-09       Impact factor: 6.150

10.  Corticotropin-Releasing Factor in the Brain and Blocking Spinal Descending Signals Induce Hyperalgesia in the Latent Sensitization Model of Chronic Pain.

Authors:  Wenling Chen; Yvette Taché; Juan Carlos Marvizón
Journal:  Neuroscience       Date:  2018-06-15       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.